erectile dysfunction
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 20-60 years old man 1. Healthy subject who have a stable heterosexual partner for more than 3 months; 2. Mild to moderate ED (IIEF-EF between 11 and 25); 3. At least 3 months and less than 10 years on history of ED ; 4. Those who did not use PDE5-i or other ED treatments within 2 weeks prior to grouping; 5. The patient agreed to participate in the study and signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. ED caused by to endocrine or abnormal sex hormones or neurogenic factors; 2. Vascular ED caused by lesions in penile artery and cavernous; 3. Anyone with severe mental illness, spinal cord injury, abnormal penis anatomy, or penile hemangioma; 4. Hypertension with poor blood pressure control (systolic blood pressure >= 160 mmHg and diastolic blood pressure >= 100 mmHg); 5. Diabetes with poor glycemic control, fasting plasma glucose (FPG) levels > 7.0 mmol / l (126 mg / dl); 6. Chronic blood system diseases, or severe respiratory, digestive, and central nervous diseases with clinical significance; 7. Patients who have undergone radical prostatectomy, pelvic surgery or radical prostatectomy in the past; 8. Who has been recovering from cancer in the past year or after undergoing radiotherapy in the pelvic region; 9. ED due to use of anti-androgen, androgen drugs; coagulation dysfunction and anticoagulant (such as Coumadin); 10. Have participated in any other medical device or clinical researcher in the past 3 months; or other patients who are considered unsuitable for participation in this trial.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| SEP;GAQ;EHS;Satisfaction score of erectile;SEAR; | — |
Primary
| Measure | Time frame |
|---|---|
| IIEF-EF; | — |
Countries
China
Contacts
Shanghai General Hospital